EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022

Monica Jung iD, Ting Xia, Jenni Ilomäki, Christopher Pearce, Angela Aitken, Suzanne Nielsen

Pain Medicine · 01.12.2024 · 25 (12) · 748-757

DOI: 10.1093/pm/pnae071 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pain Medicine, online erschienen am 06.08.2024. Verfasst von Monica Jung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3199, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian National Health and Medical Research Council, National Health and Medical Research Council, Monash Addiction Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the predictors of persistent opioid use (“persistence”) in people initiating opioids for non-cancer pain in Australian primary care.

Design

A retrospective cohort study.

Setting

Australian primary care. Subjects People prescribed opioid analgesics between 2018 and 2022, identified through the Population Level Analysis and Reporting (POLAR) database.

Methods

Persistence was defined as receiving opioid prescriptions for at least 90 days with a gap of less than 60 days between subsequent prescriptions. Multivariable logistic regression was used to examine the predictors of persistent opioid use.

Results

The sample consisted of 343 023 people initiating opioids for non-cancer pain; of these, 16 527 (4.8%) developed persistent opioid use. Predictors of persistence included older age (≥75 vs 15–44 years: adjusted odds ratio: 1.67, 95% CI: 1.58–1.78); concessional beneficiary status (1.78, 1.71–1.86); diagnosis of substance use disorder (1.44, 1.22–1.71) or chronic pain (2.05, 1.85–2.27); initiation of opioid therapy with buprenorphine (1.95, 1.73–2.20) or long-acting opioids (2.07, 1.90–2.25); provision of higher quantity of opioids prescribed at initiation (total oral morphine equivalents of ≥750 mg vs <100 mg: 7.75, 6.89–8.72); provision of repeat/refill opioid prescriptions at initiation (2.94, 2.77–3.12); and prescription of gabapentinoids (1.59, 1.50–1.68), benzodiazepines (1.43, 1.38–1.50), and z-drugs (eg, zopiclone, zolpidem; 1.61, 1.46–1.78).

Conclusions

These findings add to the limited evidence of individual-level factors associated with persistent opioid use. Further research is needed to understand the clinical outcomes of persistent opioid use in people with these risk factors to support the safe and effective prescribing of opioids.

Schlagwörter

Stichwörter der Autor:innen

general practicelong-term opioid usenon-cancer painopioid analgesicspersistent opioid useprimary care

Autor:innen und Institutionen

  • Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3199, Australia.
  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria 3052, Australia.
  • Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia.
  • Aurora Primary Care Research Institute, Melbourne, Victoria 3130, Australia.
  • Department of General Practice, School of Primary and Allied Health Care, Monash University, Melbourne, Victoria 3168, Australia.
  • Gippsland Primary Health Network, Traralgon, Victoria 3844, Australia.

ORCID-Profile: Monica Jung

Förderung

  • Australian National Health and Medical Research Council
  • National Health and Medical Research Council
  • Monash Addiction Research Centre

Zitieren

APA

Jung, M., Xia, T., Ilomäki, J., Pearce, C., Aitken, A., & Nielsen, S. (2024). Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022. Pain Medicine, 25(12), 748-757. https://doi.org/10.1093/pm/pnae071

Vancouver

Jung M, Xia T, Ilomäki J, Pearce C, Aitken A, Nielsen S. Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022. Pain Medicine. 2024;25(12):748-757. doi:10.1093/pm/pnae071

BibTeX
@article{Jung2024,
  author = {Jung, Monica and Xia, Ting and Ilomäki, Jenni and Pearce, Christopher and Aitken, Angela and Nielsen, Suzanne},
  title = {Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022},
  journal = {Pain Medicine},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {748--757},
  doi = {10.1093/pm/pnae071}
}
Kostenlos starten →